Two Sigma Advisers’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-214,800
| Closed | -$41K | – | 2424 |
|
|
2025
Q3 | $41K | Sell |
214,800
-46,000
| -18% | -$55.1K | ﹤0.01% | 2278 |
|
|
2025
Q2 | $443K | Sell |
260,800
-15,300
| -6% | -$25.8K | ﹤0.01% | 1802 |
|
|
2025
Q1 | $436K | Buy |
276,100
+193,500
| +234% | +$327K | ﹤0.01% | 1837 |
|
|
2024
Q4 | $148K | Buy |
+82,600
| New | +$263K | ﹤0.01% | 2168 |
|
|
2023
Q4 | – | Sell |
-56,900
| Closed | -$176K | – | 2540 |
|
|
2023
Q3 | $176K | Sell |
56,900
-25,400
| -31% | -$73.2K | ﹤0.01% | 2118 |
|
|
2023
Q2 | $222K | Sell |
82,300
-141,500
| -63% | -$415K | ﹤0.01% | 2067 |
|
|
2023
Q1 | $665K | Buy |
223,800
+51,700
| +30% | +$152K | ﹤0.01% | 1824 |
|
|
2022
Q4 | $434K | Sell |
172,100
-170,300
| -50% | -$489K | ﹤0.01% | 1935 |
|
|
2022
Q3 | $623K | Buy |
342,400
+291,300
| +570% | +$768K | ﹤0.01% | 1749 |
|
|
2022
Q2 | $161K | Sell |
51,100
-61,900
| -55% | -$346K | ﹤0.01% | 2316 |
|
|
2022
Q1 | $698K | Sell |
113,000
-43,500
| -28% | -$382K | ﹤0.01% | 1822 |
|
|
2021
Q4 | $2.22M | Sell |
156,500
-408,300
| -72% | -$4.55M | 0.01% | 1142 |
|
|
2021
Q3 | $4.52M | Buy |
564,800
+525,000
| +1,319% | +$8.35M | 0.01% | 837 |
|
|
2021
Q2 | $1.14M | Buy |
39,800
+19,700
| +98% | +$573K | ﹤0.01% | 1580 |
|
|
2021
Q1 | $584K | Buy |
+20,100
| New | +$467K | ﹤0.01% | 1950 |
|